Plasma adenosine levels: Measurement in humans and relationship to the anxiogenic effects of caffeine-Reference-Cited by-同舟云学术

Plasma adenosine levels: Measurement in humans and relationship to the anxiogenic effects of caffeine

Published:1987-07 Issue:3 Volume:21 Page:247-255
ISSN:0165-1781
Container-title:Psychiatry Research
language:en
Short-container-title:Psychiatry Research

Author:

Boulenger Jean-Philippe,Salem Norman,Marangos Paul J.,Uhde Thomas W.

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference42 articles.

1. Effects of caffeine and theophylline on adenosine and benzodiazepine receptors in human brain;Boulenger;Neuroscience Letters,1982

2. Caffeine consumption and anxiety: Preliminary results of a survey comparing patients with anxiety disorders and normal controls;Boulanger;Psychopharmacology Bulletin,1982

3. Anxiogenic effects of caffeine in normal controls and patients with panic disorder;Boulenger,1986

4. Increased sensitivity to caffeine in patients with panic disorders: Preliminary evidence;Boulenger;Archives of General Psychiatry,1984

5. Quantification without purification of blood and tissue adenosine by radioimmunoassay;Bredehorst;Annals of Biochemistry,1983

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Aptameric Microfluidic System for Specific Purification, Enrichment, and Mass Spectrometric Detection of Biomolecules;Journal of Microelectromechanical Systems;2009-12

2. Preference for caffeine appears earlier in non-anxious than in anxious mice;Neuroscience Letters;2005-09

3. Ethopharmacological analysis of the unstable elevated exposed plus maze, a novel model of extreme anxiety: predictive validity and sensitivity to anxiogenic agents;Psychopharmacology;2002-05-01

4. Caffeine in the modulation of brain function;Caffeine and Behavior;1999-05-20

5. Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease;Molecular Psychiatry;1998-01